Masimo Appoints New Chief Medical Officer, Legal Counsel Departs

Ticker: MASI · Form: 8-K · Filed: May 8, 2024 · CIK: 937556

Masimo CORP 8-K Filing Summary
FieldDetail
CompanyMasimo CORP (MASI)
Form Type8-K
Filed DateMay 8, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: executive-appointment, executive-departure, personnel-change

Related Tickers: MASI

TL;DR

Masimo names new CMO, legal chief exits.

AI Summary

Masimo Corporation announced on May 8, 2024, that its Board of Directors has appointed Dr. David Bruce as Chief Medical Officer, effective May 3, 2024. Dr. Bruce will also serve as a member of the company's executive leadership team. The filing also notes the departure of Todd L. Cooper from his role as Senior Vice President, Chief Legal Officer and General Counsel.

Why It Matters

The appointment of a new Chief Medical Officer can signal a strategic shift in the company's medical product development or market focus. The departure of a key legal officer may raise questions about internal governance or ongoing legal matters.

Risk Assessment

Risk Level: medium — Changes in executive leadership, particularly in critical roles like CMO and Chief Legal Officer, can introduce uncertainty regarding future strategy and operations.

Key Players & Entities

FAQ

Who has been appointed as the new Chief Medical Officer at Masimo Corporation?

Dr. David Bruce has been appointed as the new Chief Medical Officer, effective May 3, 2024.

When was Dr. David Bruce's appointment as Chief Medical Officer effective?

Dr. David Bruce's appointment was effective May 3, 2024.

Who has departed from Masimo Corporation's executive team?

Todd L. Cooper has departed from his role as Senior Vice President, Chief Legal Officer and General Counsel.

What is Masimo Corporation's principal executive office address?

Masimo Corporation's principal executive office is located at 52 Discovery, Irvine, CA 92618.

What is the filing date for this Current Report on Form 8-K?

The filing date for this Current Report on Form 8-K is May 8, 2024.

Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2024-05-08 16:45:23

Key Financial Figures

Filing Documents

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) The following item is filed as an exhibit to the Current Report on Form 8-K. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, Masimo Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MASIMO CORPORATION Date: May 8, 2024 By: /s/ MICAH YOUNG Micah Young Executive Vice President & Chief Financial Officer (Principal Financial Officer) 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing